» Articles » PMID: 37279752

Platelets and Mast Cells Promote Pathogenic Eosinophil Recruitment During Invasive Fungal Infection Via the 5-HIAA-GPR35 Ligand-receptor System

Overview
Journal Immunity
Publisher Cell Press
Date 2023 Jun 6
PMID 37279752
Authors
Affiliations
Soon will be listed here.
Abstract

Cryptococcus neoformans is the leading cause of fungal meningitis and is characterized by pathogenic eosinophil accumulation in the context of type-2 inflammation. The chemoattractant receptor GPR35 is expressed by granulocytes and promotes their migration to the inflammatory mediator 5-hydroxyindoleacetic acid (5-HIAA), a serotonin metabolite. Given the inflammatory nature of cryptococcal infection, we examined the role of GPR35 in the circuitry underlying cell recruitment to the lung. GPR35 deficiency dampened eosinophil recruitment and fungal growth, whereas overexpression promoted eosinophil homing to airways and fungal replication. Activated platelets and mast cells were the sources of GPR35 ligand activity and pharmacological inhibition of serotonin conversion to 5-HIAA, or genetic deficiency in 5-HIAA production by platelets and mast cells resulted in more efficient clearance of Cryptococcus. Thus, the 5-HIAA-GPR35 axis is an eosinophil chemoattractant receptor system that modulates the clearance of a lethal fungal pathogen, with implications for the use of serotonin metabolism inhibitors in the treatment of fungal infections.

Citing Articles

Inhibition of 5-hydroxyindoleacetic acid to reduce neutrophil extracellular trap production improves lung condition in chronic obstructive pulmonary disease mice.

Zeng Q, Xue L, Li W, Liang C, Zhou W, Xiong W Ann Med. 2025; 57(1):2474734.

PMID: 40066951 PMC: 11899248. DOI: 10.1080/07853890.2025.2474734.


The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy.

Inverso D, Tacconi C, Ranucci S, De Giovanni M Eur J Immunol. 2024; 54(12):e2350870.

PMID: 39263783 PMC: 11628915. DOI: 10.1002/eji.202350870.


Inbred Mouse Models in Research.

Ding M, Nielsen K J Fungi (Basel). 2024; 10(6).

PMID: 38921412 PMC: 11204852. DOI: 10.3390/jof10060426.


The tryptophan metabolic pathway of the microbiome and host cells in health and disease.

Miyamoto K, Sujino T, Kanai T Int Immunol. 2024; 36(12):601-616.

PMID: 38869080 PMC: 11562643. DOI: 10.1093/intimm/dxae035.


Mast cells help organize the Peyer's patch niche for induction of IgA responses.

De Giovanni M, Vykunta V, Biram A, Chen K, Taglinao H, An J Sci Immunol. 2024; 9(93):eadj7363.

PMID: 38427721 PMC: 11008922. DOI: 10.1126/sciimmunol.adj7363.


References
1.
Pereira J, An J, Xu Y, Huang Y, Cyster J . Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat Immunol. 2009; 10(4):403-11. PMC: 2768754. DOI: 10.1038/ni.1710. View

2.
Schneditz G, Elias J, Pagano E, Cader M, Saveljeva S, Long K . GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump. Sci Signal. 2019; 12(562). PMC: 6364804. DOI: 10.1126/scisignal.aau9048. View

3.
Shah S, Page C, Pitchford S . Platelet-Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma. Front Med (Lausanne). 2017; 4:129. PMC: 5550710. DOI: 10.3389/fmed.2017.00129. View

4.
Garcia-Rodriguez K, Bini E, Gamboa-Dominguez A, Espitia-Pinzon C, Huerta-Yepez S, Bulfone-Paus S . Differential mast cell numbers and characteristics in human tuberculosis pulmonary lesions. Sci Rep. 2021; 11(1):10687. PMC: 8140073. DOI: 10.1038/s41598-021-89659-6. View

5.
Rhein J, Morawski B, Hullsiek K, Nabeta H, Kiggundu R, Tugume L . Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Lancet Infect Dis. 2016; 16(7):809-818. PMC: 4927382. DOI: 10.1016/S1473-3099(16)00074-8. View